The minimal invasive surfactant therapy: experience from a low resource setting.

Objective: To evaluate all cases managed with the Minimal Invasive Surfactant Therapy (MIST) and its effect on outcome.

Background: Respiratory distress syndrome (RDS), a major cause of morbidity and mortality in preterm new-borns is common in sub-Saharan Africa. Surfactant replacement therapy (SRT) is less practiced and the new MIST is just introduced in Asaba, Nigeria.